Absorption and distribution profile of all α-benzyl amino coumarin compoundsa.
| Entry | HIA | Caco-2 permeability | BBB | P-Glycoprotein | Plasma protein bonding (PPB) |
|---|---|---|---|---|---|
| 1 | 95.89 | 40.71 | 0.53 | NS/NI | 84.19 |
| 2 | 96.35 | 32.78 | 1.36 | NS/NI | 88.44 |
| 3 | 96.35 | 33.20 | 1.45 | NS/NI | 95.61 |
| 4 | 95.99 | 42.25 | 1.07 | NS/NI | 84.00 |
| 5 | 95.99 | 41.68 | 1.27 | NS/NI | 84.18 |
| 6 | 95.94 | 43.59 | 0.18 | NS/NI | 83.07 |
| 7 | 96.28 | 46.85 | 3.17 | NS/NI | 86.23 |
| 8 | 96.85 | 21.52 | 0.01 | NS/NI | 88.55 |
| 9 | 96.73 | 36.52 | 3.21 | NS/NI | 98.25 |
| 10 | 96.04 | 44.79 | 1.02 | NS/NI | 85.61 |
| 11 | 95.79 | 36.93 | 0.89 | NS/NI | 78.15 |
| 12 | 96.55 | 29.35 | 0.82 | NS/NI | 100 |
| 13 | 96.26 | 30.41 | 0.72 | NS/NI | 89.90 |
| 14 | 96.50 | 16.70 | 0.01 | NS/NI | 82.31 |
| 15 | 95.89 | 38.05 | 0.60 | NS/NI | 80.51 |
| 16 | 95.87 | 40.30 | 0.10 | NS/NI | 78.83 |
| 17 | 96.50 | 21.34 | 0.01 | NS/NI | 83.07 |
| 18 | 95.83 | 37.64 | 0.60 | NS/NI | 51.66 |
| 19 | 96.46 | 29.18 | 0.15 | NS/NI | 91.28 |
| 20 | 96.16 | 30.91 | 0.14 | NS/NI | 78.08 |
| 21 | 95.23 | 9.96 | 0.01 | NS/NI | 66.81 |
| 22 | 95.88 | 38.05 | 0.07 | NS/NI | 60.53 |
| 23 | 96.59 | 33.57 | 0.27 | NS/NI | 86.02 |
| 24 | 96.59 | 33.64 | 0.50 | NS/NI | 88.18 |
NS = non-substrate; NI = non-inhibitor; S = substrate; I = inhibitor.